|
Welcome Fredhager.com and CurrinResearch.com subscribers, Thank you for your interest in CurrinBiotech.com. The CurrinBiotech newsletter is a monthly e-newsletter service complete with portfolio selections, special updates and features, and transaction alerts. Your first issue will arrive August 4, 2010. The annual subscription is $350. As a special opportunity to existing Fredhager.com and CurrinResearch.com subscribers we are offering a 50% off charter membership for $175. You also get 2 extra months with your first year’s subscription. You’ll get to keep this 50% off charter membership rate as long as you remain subscribers. What you get: Companies in Focus Each month we cover the investments selected for developments important to your investment decisions. This includes looking at parallel development and pipeline activity and the business model as applied to your investment. Breaking Science Each month we take a look at the science of the biotech area. While biotech companies will often deliver press releases on the positive developments in an animal or clinical study, scientific research can often define the true under the radar direction of drug candidates. We look at breaking science for what it gives us as confirmation or perhaps even contradiction of investments. By using this approach you stay invested in the most promising science and avoid the disasters of late stage disappointments. Gems on the Forefront We deliver the gems on the forefront each month. No biotech investment portfolio is complete without some exposure to mid stage developments. While a mix of mid stage and later stage pipelines is important generally, it is the early to mid stage areas that provide the 10 to 20 baggers as well as the huge upside potential of partnerships and acquisitions by big pharma in the long term. Also looking at mid stage developments (and sometimes even early developments and non-publicly traded activity) gives you early signals on what late stage drugs are facing in terms of promise and pitfalls. By taking a look at gems on the forefront in every issue we arm you with the knowledge to navigate biotech for the largest profits. We will show you in every issue that hidden gems are not so hidden after all. Stock Selection and Portfolios We feature model portfolios for our selections. You have access to all the portfolio information and recommendations in the member area as well as access to archived content and alerts. Unlimited Online Access, Alerts and Special Features In addition to the monthly service for tracking your investment decisions, you will also receive email alerts for transactions and special feature reports as supplemental reports. All of the information in the monthly service is available online with unlimited access. A Simple Effective Approach The CurrinBiotech newsletter is easy to use and understand. Buy the longer term portfolio stocks we feature in our portfolio section and monitor the investments as well as market developments with our newsletter and transaction alerts. While the system is simplicity in action, it is knowing which stocks to select based on knowledge of the science and innovation and market potential that is key to its success. That's where the research of the CurrinBiotech and our collaboration team comes in to bring you clear, confident, money-making picks. |